Market Scenario
Global Connected Drug Delivery Devices Market was valued US$ 138.19 Mn in 2017 and is expected to reach US$ 812.3 Mn by 2026, at a CAGR of 24.78% during a forecast period.
The connected drug delivery devices market is majorly segmented into product, end-user, technology, disease indication type, treatment type, and region.
Further, connected drug delivery devices market based on product includes connected sensors, and integrated connected devices. Connected drug delivery devices market in terms of end-user is classified into healthcare providers, and homecare centres. Based on connected drug delivery devices market, technology segment is divided into bluetooth, NFC, and other technologies. In terms of disease indication type segment connected drug delivery devices market is categorized into gastric neuroendocrine tumours, lung neuroendocrine tumours, pancreatic neuroendocrine tumours, and appendiceal neuroendocrine tumours. Further, connected drug delivery devices market based on treatment type includes somatostatin analogs, targeted therapy, and chemotherapy.
Based on regions, the global connected drug delivery devices market is divided into five main regions are America, Europe, Asia-pacific, Latin America and Middle East & Africa.
Global Connected Drug Delivery Devices Market
On the basis of the end-user, the healthcare providers segment led the market with a revenue share and is expected to witness a lucrative market growth during forecast period due to increasing cases of diabetes, Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease, and other chronic diseases are anticipated to create the need for efficient health record systems.
In terms of technology, Bluetooth segment led the market with the highest revenue share and is expected to witness lucrative growth during the forecast period due to a large number of connected drug delivery systems work with Bluetooth as it is easily available and cheaper as compared to other technologies. However, other technologies segment is expected to emerge as the fastest-growing segment in the next few years.
The major driving factor is the rising preference for injectable drug delivery is anticipated to drive the market for antiseptic drugs globally. Self-administration of drugs through the usage of pre-filled syringes is one of the ways that can help patients to save the fees given to a caregiver. There is an increased demand for large molecule drugs in pre-filled syringes as compared to small molecule drugs in pre-filled syringes.
The high price of connected drug delivery devices is anticipated to one of the significant factors in impeding market growth. Additionally, limited knowledge and adoption rate among patients to hinder growth rate.
In terms of region, North America accounted for the largest revenue share and is expected to lead the market over the forecast period owing to quick adoption of latest technologies and devices, high per capita healthcare expenditure, and raising awareness regarding the adverse effects of non-adherence to medication.
Key players operating in the global connected drug delivery devices market are Bayer AG, Propeller Health, West Pharmaceutical Services, Inc, 3M Company, OPKO Health, Sagentia, Cohero Health, Care TRx, CeQur SA, and Biocorp Production SA.
Scope of Global Connected Drug Delivery Devices Market:
Global Connected Drug Delivery Devices Market, by Product:
• Connected Sensors
• Integrated Connected Devices
Global Connected Drug Delivery Devices Market, by End-User:
• Healthcare Providers
• Homecare Centres
Global Connected Drug Delivery Devices Market, by Technology:
• Bluetooth
• NFC
• Other Technologies
Global Connected Drug Delivery Devices Market by Disease Indication Type:
• Gastric Neuroendocrine Tumours
• Lung Neuroendocrine Tumours
• Pancreatic Neuroendocrine Tumours
• Appendiceal Neuroendocrine Tumours
Global Connected Drug Delivery Devices Market by Treatment Type:
• Somatostatin Analogs
• Targeted Therapy
• Chemotherapy
Global Connected Drug Delivery Devices Market, by Region:
• North America
• Europe
• Middle East & Africa
• Asia Pacific
• Latin America
Key players operating in Global Connected Drug Delivery Devices Market:
• Bayer AG
• Propeller Health
• West Pharmaceutical Services, Inc
• 3M Company
• OPKO Health
• Sagentia
• Cohero Health
• Care TRx
• CeQur SA
• Biocorp Production SA
Table of Contents
Global Connected Drug Delivery Devices Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
1.4. Key Questions Answered
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Connected Drug Delivery Devices Market Size, by Market Value (US$ Bn) and Market, by Region
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
4.4. Global Connected Drug Delivery Devices Market Industry Trends and Emerging Technologies
5. Global Connected Drug Delivery Devices Market Analysis and Forecast
5.1. Global Connected Drug Delivery Devices Market Analysis and Forecast
5.2. Global Connected Drug Delivery Devices Market Size & Y-o-Y Growth Analysis
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Middle East & Africa
5.2.5. Latin America
6. Global Connected Drug Delivery Devices Market Analysis and Forecast, by Product
6.1. Introduction and Definition
6.2. Key Findings
6.3. Global Connected Drug Delivery Devices Market Value Share Analysis, by Product
6.4. Global Connected Drug Delivery Devices Market Size (US$ Bn) Forecast, by Product
6.5. Global Connected Drug Delivery Devices Market Analysis, by Product
6.6. Global Connected Drug Delivery Devices Market Attractiveness Analysis, by Product
7. Global Connected Drug Delivery Devices Market Analysis and Forecast, by End-user
7.1. Introduction and Definition
7.2. Global Connected Drug Delivery Devices Market Value Share Analysis, by End-user
7.3. Global Connected Drug Delivery Devices Market Size (US$ Bn) Forecast, by End-user
7.4. Global Connected Drug Delivery Devices Market Analysis, by End-user
7.5. Global Connected Drug Delivery Devices Market Attractiveness Analysis, by End-user
8. Global Connected Drug Delivery Devices Market Analysis and Forecast, by Technology
8.1. Introduction and Definition
8.2. Global Connected Drug Delivery Devices Market Value Share Analysis, by Technology
8.3. Global Connected Drug Delivery Devices Market Size (US$ Bn) Forecast, by Technology
8.4. Global Connected Drug Delivery Devices Market Analysis, by Technology
8.5. Global Connected Drug Delivery Devices Market Attractiveness Analysis, by Technology
9. Global Connected Drug Delivery Devices Market Analysis and Forecast, by Disease Indication Type
9.1. Introduction and Definition
9.2. Global Connected Drug Delivery Devices Market Value Share Analysis, by Disease Indication Type
9.3. Global Connected Drug Delivery Devices Market Size (US$ Bn) Forecast, by Disease Indication Type
9.4. Global Connected Drug Delivery Devices Market Analysis, by Disease Indication Type
9.5. Global Connected Drug Delivery Devices Market Attractiveness Analysis, by Disease Indication Type
10. Global Connected Drug Delivery Devices Market Analysis and Forecast, by Treatment Type
10.1. Introduction and Definition
10.2. Global Connected Drug Delivery Devices Market Value Share Analysis, by Treatment Type
10.3. Global Connected Drug Delivery Devices Market Size (US$ Bn) Forecast, by Treatment Type
10.4. Global Connected Drug Delivery Devices Market Analysis, by Treatment Type
10.5. Global Connected Drug Delivery Devices Market Attractiveness Analysis, by Treatment Type
11. Global Connected Drug Delivery Devices Market Analysis, by Region
11.1. Global Connected Drug Delivery Devices Market Value Share Analysis, by Region
11.2. Global Connected Drug Delivery Devices Market Size (US$ Bn) Forecast, by Region
11.3. Global Connected Drug Delivery Devices Market Attractiveness Analysis, by Region
12. North America Connected Drug Delivery Devices Market Analysis
12.1. Key Findings
12.2. North America Connected Drug Delivery Devices Market Overview
12.3. North America Connected Drug Delivery Devices Market Value Share Analysis, by Product
12.4. North America Connected Drug Delivery Devices Market Forecast, by Product
12.4.1. Connected Sensors
12.4.2. Integrated Connected Devices
12.5. North America Connected Drug Delivery Devices Market Value Share Analysis, by End-user
12.6. North America Connected Drug Delivery Devices Market Forecast, by End-user
12.6.1. Healthcare Providers
12.6.2. Homecare Centres
12.7. North America Connected Drug Delivery Devices Market Value Share Analysis, by Technology
12.8. North America Connected Drug Delivery Devices Market Forecast, by Technology
12.8.1. Bluetooth
12.8.2. NFC
12.8.3. Other Technologies
12.9. North America Connected Drug Delivery Devices Market Value Share Analysis, by Disease Indication Type
12.10. North America Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
12.10.1. Gastric Neuroendocrine Tumours
12.10.2. Lung Neuroendocrine Tumours
12.10.3. Pancreatic Neuroendocrine Tumours
12.10.4. Appendiceal Neuroendocrine Tumours
12.11. North America Connected Drug Delivery Devices Market Value Share Analysis, by Treatment Type
12.12. North America Connected Drug Delivery Devices Market Forecast, by Treatment Type
12.12.1. Somatostatin Analogs
12.12.2. Targeted Therapy
12.12.3. Chemotherapy
12.13. North America Connected Drug Delivery Devices Market Value Share Analysis, by Country
12.14. North America Connected Drug Delivery Devices Market Forecast, by Country
12.14.1. U.S.
12.14.2. Canada
12.15. North America Connected Drug Delivery Devices Market Analysis, by Country
12.16. U.S. Connected Drug Delivery Devices Market Forecast, by Product
12.16.1. Connected Sensors
12.16.2. Integrated Connected Devices
12.17. U.S. Connected Drug Delivery Devices Market Forecast, by End-user
12.17.1. Healthcare Providers
12.17.2. Homecare Centres
12.18. U.S. Connected Drug Delivery Devices Market Forecast, by Technology
12.18.1. Bluetooth
12.18.2. NFC
12.18.3. Other Technologies
12.19. U.S. Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
12.19.1. Gastric Neuroendocrine Tumours
12.19.2. Lung Neuroendocrine Tumours
12.19.3. Pancreatic Neuroendocrine Tumours
12.19.4. Appendiceal Neuroendocrine Tumours
12.20. U.S. Connected Drug Delivery Devices Market Forecast, by Treatment Type
12.20.1. Somatostatin Analogs
12.20.2. Targeted Therapy
12.20.3. Chemotherapy
12.21. Canada Connected Drug Delivery Devices Market Forecast, by Product
12.21.1. Connected Sensors
12.21.2. Integrated Connected Devices
12.22. Canada Connected Drug Delivery Devices Market Forecast, by End-user
12.22.1. Healthcare Providers
12.22.2. Homecare Centres
12.23. Canada Connected Drug Delivery Devices Market Forecast, by Technology
12.23.1. Bluetooth
12.23.2. NFC
12.23.3. Other Technologies
12.24. Canada Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
12.24.1. Gastric Neuroendocrine Tumours
12.24.2. Lung Neuroendocrine Tumours
12.24.3. Pancreatic Neuroendocrine Tumours
12.24.4. Appendiceal Neuroendocrine Tumours
12.25. Canada Connected Drug Delivery Devices Market Forecast, by Treatment Type
12.25.1. Somatostatin Analogs
12.25.2. Targeted Therapy
12.25.3. Chemotherapy
12.26. North America Connected Drug Delivery Devices Market Attractiveness Analysis
12.26.1. By Product
12.26.2. By End-user
12.26.3. By Technology
12.26.4. By Disease Indication Type
12.26.5. By Treatment Type
12.27. PEST Analysis
13. Europe Connected Drug Delivery Devices Market Analysis
13.1. Key Findings
13.2. Europe Connected Drug Delivery Devices Market Overview
13.3. Europe Connected Drug Delivery Devices Market Value Share Analysis, by Product
13.4. Europe Connected Drug Delivery Devices Market Forecast, by Product
13.4.1. Connected Sensors
13.4.2. Integrated Connected Devices
13.5. Europe Connected Drug Delivery Devices Market Value Share Analysis, by End-user
13.6. Europe Connected Drug Delivery Devices Market Forecast, by End-user
13.6.1. Healthcare Providers
13.6.2. Homecare Centres
13.7. Europe Connected Drug Delivery Devices Market Value Share Analysis, by Technology
13.8. Europe Connected Drug Delivery Devices Market Forecast, by Technology
13.8.1. Bluetooth
13.8.2. NFC
13.8.3. Other Technologies
13.9. Europe Connected Drug Delivery Devices Market Value Share Analysis, by Disease Indication Type
13.10. Europe Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
13.10.1. Gastric Neuroendocrine Tumours
13.10.2. Lung Neuroendocrine Tumours
13.10.3. Pancreatic Neuroendocrine Tumours
13.10.4. Appendiceal Neuroendocrine Tumours
13.11. Europe Connected Drug Delivery Devices Market Value Share Analysis, by Treatment Type
13.12. Europe Connected Drug Delivery Devices Market Forecast, by Treatment Type
13.12.1. Somatostatin Analogs
13.12.2. Targeted Therapy
13.12.3. Chemotherapy
13.13. Europe Connected Drug Delivery Devices Market Value Share Analysis, by Country
13.14. Europe Connected Drug Delivery Devices Market Forecast, by Country
13.14.1. Germany
13.14.2. U.K.
13.14.3. France
13.14.4. Italy
13.14.5. Spain
13.14.6. Rest of Europe
13.15. Europe Connected Drug Delivery Devices Market Analysis, by Country/ Sub-region
13.16. Germany Connected Drug Delivery Devices Market Forecast, by Product
13.16.1. Connected Sensors
13.16.2. Integrated Connected Devices
13.17. Germany Connected Drug Delivery Devices Market Forecast, by End-user
13.17.1. Healthcare Providers
13.17.2. Homecare Centres
13.18. Germany Connected Drug Delivery Devices Market Forecast, by Technology
13.18.1. Bluetooth
13.18.2. NFC
13.18.3. Other Technologies
13.19. Germany Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
13.19.1. Gastric Neuroendocrine Tumours
13.19.2. Lung Neuroendocrine Tumours
13.19.3. Pancreatic Neuroendocrine Tumours
13.19.4. Appendiceal Neuroendocrine Tumours
13.20. Germany Connected Drug Delivery Devices Market Forecast, by Treatment Type
13.20.1. Somatostatin Analogs
13.20.2. Targeted Therapy
13.20.3. Chemotherapy
13.21. U.K. Connected Drug Delivery Devices Market Forecast, by Product
13.21.1. Connected Sensors
13.21.2. Integrated Connected Devices
13.22. U.K. Connected Drug Delivery Devices Market Forecast, by End-user
13.22.1. Healthcare Providers
13.22.2. Homecare Centres
13.23. U.K. Connected Drug Delivery Devices Market Forecast, by Technology
13.23.1. Bluetooth
13.23.2. NFC
13.23.3. Other Technologies
13.24. U.K. Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
13.24.1. Gastric Neuroendocrine Tumours
13.24.2. Lung Neuroendocrine Tumours
13.24.3. Pancreatic Neuroendocrine Tumours
13.24.4. Appendiceal Neuroendocrine Tumours
13.25. U.K. Connected Drug Delivery Devices Market Forecast, by Treatment Type
13.25.1. Somatostatin Analogs
13.25.2. Targeted Therapy
13.25.3. Chemotherapy
13.26. France Connected Drug Delivery Devices Market Forecast, by Product
13.26.1. Connected Sensors
13.26.2. Integrated Connected Devices
13.27. France Connected Drug Delivery Devices Market Forecast, by End-user
13.27.1. Healthcare Providers
13.27.2. Homecare Centres
13.28. France Connected Drug Delivery Devices Market Forecast, by Technology
13.28.1. Bluetooth
13.28.2. NFC
13.28.3. Other Technologies
13.29. France Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
13.29.1. Gastric Neuroendocrine Tumours
13.29.2. Lung Neuroendocrine Tumours
13.29.3. Pancreatic Neuroendocrine Tumours
13.29.4. Appendiceal Neuroendocrine Tumours
13.30. France Connected Drug Delivery Devices Market Forecast, by Treatment Type
13.30.1. Somatostatin Analogs
13.30.2. Targeted Therapy
13.30.3. Chemotherapy
13.31. Italy Connected Drug Delivery Devices Market Forecast, by Product
13.31.1. Connected Sensors
13.31.2. Integrated Connected Devices
13.32. Italy Connected Drug Delivery Devices Market Forecast, by End-user
13.32.1. Healthcare Providers
13.32.2. Homecare Centres
13.33. Italy Connected Drug Delivery Devices Market Forecast, by Technology
13.33.1. Bluetooth
13.33.2. NFC
13.33.3. Other Technologies
13.34. Italy Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
13.34.1. Gastric Neuroendocrine Tumours
13.34.2. Lung Neuroendocrine Tumours
13.34.3. Pancreatic Neuroendocrine Tumours
13.34.4. Appendiceal Neuroendocrine Tumours
13.35. Italy Connected Drug Delivery Devices Market Forecast, by Treatment Type
13.35.1. Somatostatin Analogs
13.35.2. Targeted Therapy
13.35.3. Chemotherapy
13.36. Spain Connected Drug Delivery Devices Market Forecast, by Product
13.36.1. Connected Sensors
13.36.2. Integrated Connected Devices
13.37. Spain Connected Drug Delivery Devices Market Forecast, by End-user
13.37.1. Healthcare Providers
13.37.2. Homecare Centres
13.38. Spain Connected Drug Delivery Devices Market Forecast, by Technology
13.38.1. Bluetooth
13.38.2. NFC
13.38.3. Other Technologies
13.39. Spain Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
13.39.1. Gastric Neuroendocrine Tumours
13.39.2. Lung Neuroendocrine Tumours
13.39.3. Pancreatic Neuroendocrine Tumours
13.39.4. Appendiceal Neuroendocrine Tumours
13.40. Spain Connected Drug Delivery Devices Market Forecast, by Treatment Type
13.40.1. Somatostatin Analogs
13.40.2. Targeted Therapy
13.40.3. Chemotherapy
13.41. Rest of Europe Connected Drug Delivery Devices Market Forecast, by Product
13.41.1. Connected Sensors
13.41.2. Integrated Connected Devices
13.42. Rest of Europe Connected Drug Delivery Devices Market Forecast, by End-user
13.42.1. Healthcare Providers
13.42.2. Homecare Centres
13.43. Rest of Europe Connected Drug Delivery Devices Market Forecast, by Technology
13.43.1. Bluetooth
13.43.2. NFC
13.43.3. Other Technologies
13.44. Rest Of Europe Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
13.44.1. Gastric Neuroendocrine Tumours
13.44.2. Lung Neuroendocrine Tumours
13.44.3. Pancreatic Neuroendocrine Tumours
13.44.4. Appendiceal Neuroendocrine Tumours
13.45. Rest Of Europe Connected Drug Delivery Devices Market Forecast, by Treatment Type
13.45.1. Somatostatin Analogs
13.45.2. Targeted Therapy
13.45.3. Chemotherapy
13.46. Europe Connected Drug Delivery Devices Market Attractiveness Analysis
13.46.1. By Product
13.46.2. By End-user
13.46.3. By Technology
13.46.4. By Disease Indication Type
13.46.5. By Treatment Type
13.47. PEST Analysis
14. Asia Pacific Connected Drug Delivery Devices Market Analysis
14.1. Key Findings
14.2. Asia Pacific Connected Drug Delivery Devices Market Overview
14.3. Asia Pacific Connected Drug Delivery Devices Market Value Share Analysis, by Product
14.4. Asia Pacific Connected Drug Delivery Devices Market Forecast, by Product
14.4.1. Connected Sensors
14.4.2. Integrated Connected Devices
14.5. Asia Pacific Connected Drug Delivery Devices Market Value Share Analysis, by End-user
14.6. Asia Pacific Connected Drug Delivery Devices Market Forecast, by End-user
14.6.1. Healthcare Providers
14.6.2. Homecare Centres
14.7. Asia Pacific Connected Drug Delivery Devices Market Value Share Analysis, by Technology
14.8. Asia Pacific Connected Drug Delivery Devices Market Forecast, by Technology
14.8.1. Bluetooth
14.8.2. NFC
14.8.3. Other Technologies
14.9. Asia Pacific Connected Drug Delivery Devices Market Value Share Analysis, by Disease Indication Type
14.10. Asia Pacific Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
14.10.1. Gastric Neuroendocrine Tumours
14.10.2. Lung Neuroendocrine Tumours
14.10.3. Pancreatic Neuroendocrine Tumours
14.10.4. Appendiceal Neuroendocrine Tumours
14.11. Asia Pacific Connected Drug Delivery Devices Market Value Share Analysis, by Treatment Type
14.12. Asia Pacific Connected Drug Delivery Devices Market Forecast, by Treatment Type
14.12.1. Somatostatin Analogs
14.12.2. Targeted Therapy
14.12.3. Chemotherapy
14.13. Asia Pacific Connected Drug Delivery Devices Market Value Share Analysis, by Country
14.14. Asia Pacific Connected Drug Delivery Devices Market Forecast, by Country
14.14.1. China
14.14.2. India
14.14.3. Japan
14.14.4. ASEAN
14.14.5. Rest of Asia Pacific
14.15. Asia Pacific Connected Drug Delivery Devices Market Analysis, by Country/ Sub-region
14.16. China Connected Drug Delivery Devices Market Forecast, by Product
14.16.1. Connected Sensors
14.16.2. Integrated Connected Devices
14.17. China Connected Drug Delivery Devices Market Forecast, by End-user
14.17.1. Healthcare Providers
14.17.2. Homecare Centres
14.18. China Connected Drug Delivery Devices Market Forecast, by Technology
14.18.1. Bluetooth
14.18.2. NFC
14.18.3. Other Technologies
14.19. China Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
14.19.1. Gastric Neuroendocrine Tumours
14.19.2. Lung Neuroendocrine Tumours
14.19.3. Pancreatic Neuroendocrine Tumours
14.19.4. Appendiceal Neuroendocrine Tumours
14.20. China Connected Drug Delivery Devices Market Forecast, by Treatment Type
14.20.1. Somatostatin Analogs
14.20.2. Targeted Therapy
14.20.3. Chemotherapy
14.21. India Connected Drug Delivery Devices Market Forecast, by Product
14.21.1. Connected Sensors
14.21.2. Integrated Connected Devices
14.22. India Connected Drug Delivery Devices Market Forecast, by End-user
14.22.1. Healthcare Providers
14.22.2. Homecare Centres
14.23. India Connected Drug Delivery Devices Market Forecast, by Technology
14.23.1. Bluetooth
14.23.2. NFC
14.23.3. Other Technologies
14.24. India Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
14.24.1. Gastric Neuroendocrine Tumours
14.24.2. Lung Neuroendocrine Tumours
14.24.3. Pancreatic Neuroendocrine Tumours
14.24.4. Appendiceal Neuroendocrine Tumours
14.25. India Connected Drug Delivery Devices Market Forecast, by Treatment Type
14.25.1. Somatostatin Analogs
14.25.2. Targeted Therapy
14.25.3. Chemotherapy
14.26. Japan Connected Drug Delivery Devices Market Forecast, by Product
14.26.1. Connected Sensors
14.26.2. Integrated Connected Devices
14.27. Japan Connected Drug Delivery Devices Market Forecast, by End-user
14.27.1. Healthcare Providers
14.27.2. Homecare Centres
14.28. Japan Connected Drug Delivery Devices Market Forecast, by Technology
14.28.1. Bluetooth
14.28.2. NFC
14.28.3. Other Technologies
14.29. Japan Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
14.29.1. Gastric Neuroendocrine Tumours
14.29.2. Lung Neuroendocrine Tumours
14.29.3. Pancreatic Neuroendocrine Tumours
14.29.4. Appendiceal Neuroendocrine Tumours
14.30. Japan Connected Drug Delivery Devices Market Forecast, by Treatment Type
14.30.1. Somatostatin Analogs
14.30.2. Targeted Therapy
14.30.3. Chemotherapy
14.31. ASEAN Connected Drug Delivery Devices Market Forecast, by Product
14.31.1. Connected Sensors
14.31.2. Integrated Connected Devices
14.32. ASEAN Connected Drug Delivery Devices Market Forecast, by End-user
14.32.1. Healthcare Providers
14.32.2. Homecare Centres
14.33. ASEAN Connected Drug Delivery Devices Market Forecast, by Technology
14.33.1. Bluetooth
14.33.2. NFC
14.33.3. Other Technologies
14.34. ASEAN Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
14.34.1. Gastric Neuroendocrine Tumours
14.34.2. Lung Neuroendocrine Tumours
14.34.3. Pancreatic Neuroendocrine Tumours
14.34.4. Appendiceal Neuroendocrine Tumours
14.35. ASEAN Connected Drug Delivery Devices Market Forecast, by Treatment Type
14.35.1. Somatostatin Analogs
14.35.2. Targeted Therapy
14.35.3. Chemotherapy
14.36. Rest of Asia Pacific Connected Drug Delivery Devices Market Forecast, by Product
14.36.1. Connected Sensors
14.36.2. Integrated Connected Devices
14.37. Rest of Asia Pacific Connected Drug Delivery Devices Market Forecast, by End-user
14.37.1. Healthcare Providers
14.37.2. Homecare Centres
14.38. Rest of Asia Pacific Connected Drug Delivery Devices Market Forecast, by Technology
14.38.1. Bluetooth
14.38.2. NFC
14.38.3. Other Technologies
14.39. Rest of Asia Pacific Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
14.39.1. Gastric Neuroendocrine Tumours
14.39.2. Lung Neuroendocrine Tumours
14.39.3. Pancreatic Neuroendocrine Tumours
14.39.4. Appendiceal Neuroendocrine Tumours
14.40. Rest of Asia Pacific Connected Drug Delivery Devices Market Forecast, by Treatment Type
14.40.1. Somatostatin Analogs
14.40.2. Targeted Therapy
14.40.3. Chemotherapy
14.41. Asia Pacific Connected Drug Delivery Devices Market Attractiveness Analysis
14.41.1. By Product
14.41.2. By End-user
14.41.3. By Technology
14.41.4. By Disease Indication Type
14.41.5. By Treatment Type
14.42. PEST Analysis
15. Middle East & Africa Connected Drug Delivery Devices Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Connected Drug Delivery Devices Market Overview
15.3. Middle East & Africa Connected Drug Delivery Devices Market Value Share Analysis, by Product
15.4. Middle East & Africa Connected Drug Delivery Devices Market Forecast, by Product
15.4.1. Connected Sensors
15.4.2. Integrated Connected Devices
15.5. Middle East & Africa Connected Drug Delivery Devices Market Value Share Analysis, by End-user
15.6. Middle East & Africa Connected Drug Delivery Devices Market Forecast, by End-user
15.6.1. Healthcare Providers
15.6.2. Homecare Centres
15.7. Middle East & Africa Connected Drug Delivery Devices Market Value Share Analysis, by Technology
15.8. Middle East & Africa Connected Drug Delivery Devices Market Forecast, by Technology
15.8.1. Bluetooth
15.8.2. NFC
15.8.3. Other Technologies
15.9. Middle East & Africa Connected Drug Delivery Devices Market Value Share Analysis, by Disease Indication Type
15.10. Middle East & Africa Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
15.10.1. Gastric Neuroendocrine Tumours
15.10.2. Lung Neuroendocrine Tumours
15.10.3. Pancreatic Neuroendocrine Tumours
15.10.4. Appendiceal Neuroendocrine Tumours
15.11. Middle East & Africa Connected Drug Delivery Devices Market Value Share Analysis, by Treatment Type
15.12. Middle East & Africa Connected Drug Delivery Devices Market Forecast, by Treatment Type
15.12.1. Somatostatin Analogs
15.12.2. Targeted Therapy
15.12.3. Chemotherapy
15.13. Middle East & Africa Connected Drug Delivery Devices Market Value Share Analysis, by Country
15.14. Middle East & Africa Connected Drug Delivery Devices Market Forecast, by Country
15.14.1. GCC
15.14.2. South Africa
15.14.3. Rest of Middle East & Africa
15.15. Middle East & Africa Connected Drug Delivery Devices Market Analysis, by Country/ Sub-region
15.16. GCC Connected Drug Delivery Devices Market Forecast, by Product
15.16.1. Connected Sensors
15.16.2. Integrated Connected Devices
15.17. GCC Connected Drug Delivery Devices Market Forecast, by End-user
15.17.1. Healthcare Providers
15.17.2. Homecare Centres
15.18. GCC Connected Drug Delivery Devices Market Forecast, by Technology
15.18.1. Bluetooth
15.18.2. NFC
15.18.3. Other Technologies
15.19. GCC Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
15.19.1. Gastric Neuroendocrine Tumours
15.19.2. Lung Neuroendocrine Tumours
15.19.3. Pancreatic Neuroendocrine Tumours
15.19.4. Appendiceal Neuroendocrine Tumours
15.20. GCC Connected Drug Delivery Devices Market Forecast, by Treatment Type
15.20.1. Somatostatin Analogs
15.20.2. Targeted Therapy
15.20.3. Chemotherapy
15.21. South Africa Connected Drug Delivery Devices Market Forecast, by Product
15.21.1. Connected Sensors
15.21.2. Integrated Connected Devices
15.22. South Africa Connected Drug Delivery Devices Market Forecast, by End-user
15.22.1. Healthcare Providers
15.22.2. Homecare Centres
15.23. South Africa Connected Drug Delivery Devices Market Forecast, by Technology
15.23.1. Bluetooth
15.23.2. NFC
15.23.3. Other Technologies
15.24. South Africa Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
15.24.1. Gastric Neuroendocrine Tumours
15.24.2. Lung Neuroendocrine Tumours
15.24.3. Pancreatic Neuroendocrine Tumours
15.24.4. Appendiceal Neuroendocrine Tumours
15.25. South Africa Connected Drug Delivery Devices Market Forecast, by Treatment Type
15.25.1. Somatostatin Analogs
15.25.2. Targeted Therapy
15.25.3. Chemotherapy
15.26. Rest of Middle East & Africa Connected Drug Delivery Devices Market Forecast, by Product
15.26.1. Connected Sensors
15.26.2. Integrated Connected Devices
15.27. Rest of Middle East & Africa Connected Drug Delivery Devices Market Forecast, by End-user
15.27.1. Healthcare Providers
15.27.2. Homecare Centres
15.28. Rest of Middle East & Africa Connected Drug Delivery Devices Market Forecast, by Technology
15.28.1. Bluetooth
15.28.2. NFC
15.28.3. Other Technologies
15.29. Rest of Middle East & Africa Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
15.29.1. Gastric Neuroendocrine Tumours
15.29.2. Lung Neuroendocrine Tumours
15.29.3. Pancreatic Neuroendocrine Tumours
15.29.4. Appendiceal Neuroendocrine Tumours
15.30. Rest of Middle East & Africa Connected Drug Delivery Devices Market Forecast, by Treatment Type
15.30.1. Somatostatin Analogs
15.30.2. Targeted Therapy
15.30.3. Chemotherapy
15.31. Middle East & Africa Connected Drug Delivery Devices Market Attractiveness Analysis
15.31.1. By Product
15.31.2. By End-user
15.31.3. By Technology
15.31.4. By Disease Indication Type
15.31.5. By Treatment Type
15.32. PEST Analysis
16. Latin America Connected Drug Delivery Devices Market Analysis
16.1. Key Findings
16.2. Latin America Connected Drug Delivery Devices Market Overview
16.3. Latin America Connected Drug Delivery Devices Market Value Share Analysis, by Product
16.4. Latin America Connected Drug Delivery Devices Market Forecast, by Product
16.4.1. Connected Sensors
16.4.2. Integrated Connected Devices
16.5. Latin America Connected Drug Delivery Devices Market Value Share Analysis, by End-user
16.6. Latin America Connected Drug Delivery Devices Market Forecast, by End-user
16.6.1. Healthcare Providers
16.6.2. Homecare Centres
16.7. Latin America Connected Drug Delivery Devices Market Value Share Analysis, by Technology
16.8. Latin America Connected Drug Delivery Devices Market Forecast, by Technology
16.8.1. Bluetooth
16.8.2. NFC
16.8.3. Other Technologies
16.9. Latin America Connected Drug Delivery Devices Market Value Share Analysis, by Disease Indication Type
16.10. Latin America Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
16.10.1. Gastric Neuroendocrine Tumours
16.10.2. Lung Neuroendocrine Tumours
16.10.3. Pancreatic Neuroendocrine Tumours
16.10.4. Appendiceal Neuroendocrine Tumours
16.11. Latin America Connected Drug Delivery Devices Market Value Share Analysis, by Treatment Type
16.12. Latin America Connected Drug Delivery Devices Market Forecast, by Treatment Type
16.12.1. Somatostatin Analogs
16.12.2. Targeted Therapy
16.12.3. Chemotherapy
16.13. Latin America Connected Drug Delivery Devices Market Value Share Analysis, by Country
16.14. Latin America Connected Drug Delivery Devices Market Forecast, by Country
16.14.1. Brazil
16.14.2. Mexico
16.14.3. Rest of Latin America
16.15. Latin America Connected Drug Delivery Devices Market Analysis, by Country/ Sub-region
16.16. Brazil Connected Drug Delivery Devices Market Forecast, by Product
16.16.1. Connected Sensors
16.16.2. Integrated Connected Devices
16.17. Brazil Connected Drug Delivery Devices Market Forecast, by End-user
16.17.1. Healthcare Providers
16.17.2. Homecare Centres
16.18. Brazil Connected Drug Delivery Devices Market Forecast, by Technology
16.18.1. Bluetooth
16.18.2. NFC
16.18.3. Other Technologies
16.19. Brazil Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
16.19.1. Gastric Neuroendocrine Tumours
16.19.2. Lung Neuroendocrine Tumours
16.19.3. Pancreatic Neuroendocrine Tumours
16.19.4. Appendiceal Neuroendocrine Tumours
16.20. Brazil Connected Drug Delivery Devices Market Forecast, by Treatment Type
16.20.1. Somatostatin Analogs
16.20.2. Targeted Therapy
16.20.3. Chemotherapy
16.21. Mexico Connected Drug Delivery Devices Market Forecast, by Product
16.21.1. Connected Sensors
16.21.2. Integrated Connected Devices
16.22. Mexico Connected Drug Delivery Devices Market Forecast, by End-user
16.22.1. Healthcare Providers
16.22.2. Homecare Centres
16.23. Mexico Connected Drug Delivery Devices Market Forecast, by Technology
16.23.1. Bluetooth
16.23.2. NFC
16.23.3. Other Technologies
16.24. Mexico Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
16.24.1. Gastric Neuroendocrine Tumours
16.24.2. Lung Neuroendocrine Tumours
16.24.3. Pancreatic Neuroendocrine Tumours
16.24.4. Appendiceal Neuroendocrine Tumours
16.25. Mexico Connected Drug Delivery Devices Market Forecast, by Treatment Type
16.25.1. Somatostatin Analogs
16.25.2. Targeted Therapy
16.25.3. Chemotherapy
16.26. Rest of Latin America Connected Drug Delivery Devices Market Forecast, by Product
16.26.1. Connected Sensors
16.26.2. Integrated Connected Devices
16.27. Rest of Latin America Connected Drug Delivery Devices Market Forecast, by End-user
16.27.1. Healthcare Providers
16.27.2. Homecare Centres
16.28. Rest of Latin America Connected Drug Delivery Devices Market Forecast, by Technology
16.28.1. Bluetooth
16.28.2. NFC
16.28.3. Other Technologies
16.29. Rest of Latin America Connected Drug Delivery Devices Market Forecast, by Disease Indication Type
16.29.1. Gastric Neuroendocrine Tumours
16.29.2. Lung Neuroendocrine Tumours
16.29.3. Pancreatic Neuroendocrine Tumours
16.29.4. Appendiceal Neuroendocrine Tumours
16.30. Rest of Latin America Connected Drug Delivery Devices Market Forecast, by Treatment Type
16.30.1. Somatostatin Analogs
16.30.2. Targeted Therapy
16.30.3. Chemotherapy
16.31. Latin America Connected Drug Delivery Devices Market Attractiveness Analysis
16.31.1. By Product
16.31.2. By End-user
16.31.3. By Technology
16.31.4. By Disease Indication Type
16.31.5. By Treatment Type
16.32. PEST Analysis
17. Company Profiles
17.1. Market Share Analysis, by Company
17.2. Competition Matrix
17.3. Company Profiles: Key Players
17.3.1. Biocorp Production SA
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Business Strategy
17.3.1.4. Recent Developments
17.3.1.5. Manufacturing Footprint
17.3.2. Bayer AG
17.3.3. Propeller Health
17.3.4. West Pharmaceutical Services, Inc
17.3.5. 3M Company
17.3.6. OPKO Health
17.3.7. Sagentia (Science Group)
17.3.8. Cohero Health
17.3.9. Care TRx
17.3.10. CeQur SA
18. Primary Key Insights
